Skip to content
Review Open access

Innovative pharmacist-led hypertension management in urgent care: Bridging the gaps in cardiovascular disease

Sep 2026 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · 0 citations · 20 references

TL;DR

In an urgent care setting, pharmacist-led interventions achieved substantial reductions in blood pressure and high rates of guideline-recommended control, supporting this model as a strategy to address gaps in hypertension care for patients without primary care access.

Abstract

Hypertension control remains suboptimal, contributing to preventable cardiovascular disease events, particularly among patients with limited access to primary care. While pharmacist-led care has demonstrated benefit in primary care settings, its impact in urgent care is not well-studied. This study aimed to evaluate patient-centred outcomes of pharmacist-led interventions for hypertension management in urgent care. A pilot project was designed to integrate a pharmacist into a team-based care model to evaluate and intervene on hypertension and other cardiovascular risk factors among patients presenting to urgent care without a primary care provider and with hypertension (blood pressure ≥140/90 mmHg). The project was performed at the Metrotown Urgent and Primary Care Centre in British Columbia. A retrospective chart review was performed to evaluate the effectiveness of this project. A total of 62 patients were included (mean age 56 years; 56.5% male). Mean (standard deviation [SD]) baseline systolic/diastolic blood pressure was 178.4 (SD 21.7)/101.2 (SD 14.7) mmHg and decreased to 124.1 (SD 12.0)/77.4 (SD 9.9) mmHg following pharmacist-led care, representing a mean reduction (SD) of 54.3 (SD 19.7)/23.8 (SD 15.0) mmHg. Overall, 82% of patients were discharged from the program after achieving Hypertension Canada guideline-recommended blood pressure targets. In an urgent care setting, pharmacist-led interventions achieved substantial reductions in blood pressure and high rates of guideline-recommended control, supporting this model as a strategy to address gaps in hypertension care for patients without primary care access.

Read PDF

Similar papers

Review Sep 2026

Pharmacist-Led Remote Patient Monitoring for Hypertension: A Retrospective Evaluation of Blood Pressure Outcomes.

BACKGROUND Uncontrolled hypertension remains a leading risk factor for cardiovascular disease, particularly in rural and medically underserved populations. Remote patient monitoring (RPM) and protocol-driven care models have emerged as promising strategies to improve blood pressure (BP) control. This study evaluated a...

Carly Brown, Saurabh Chandra, Donald Clark · 0 citations
Review Open access Sep 2026

Community Pharmacy Involvement in Cardiovascular Patient Follow-Up: A Conceptual Framework for Integrated Ambulatory Pharmaceutical Care

The proposed Integrated Ambulatory Pharmaceutical Follow-Up Programme in Cardiology provides an evidence-informed conceptual framework to support the structured integration of community pharmacists into ambulatory cardiovascular care.

Lúcia Santos, Cristina Gavina, Jorge Oliveira et al. · 0 citations
Review Open access Sep 2026

Team-Based Hypertension Management in Primary Care: A Synthesis of Systematic Reviews.

BACKGROUND People with hypertension often require personalised education and support from health professionals to optimise outcomes. Multidisciplinary team-based care in primary care has been proposed as a strategy to empower patients to manage their blood pressure. Although substantial literature reports team-based in...

Elizabeth Halcomb, K. Kuzmins, Emily de Tourettes et al. · 0 citations
Open access Sep 2026

Understanding therapeutic inertia in the management of hypertension in primary care: examining contributing factors at the patient and provider levels in Chittoor District, Andhra Pradesh, India – a mixed methods study

Hypertension remains a significant global health challenge, affecting approximately 1.4 billion adults aged 30–79 worldwide. In India, the age-standardised prevalence is 28.1%, and blood pressure (BP) control remains suboptimal. Therapeutic inertia, the failure to initiate or intensify treatment when therapeutic...

Shruti Krishnan, Dorothy Lall, Harsh Shah · 0 citations
Open access Sep 2026

Clinical inertia in cardiovascular risk management: prevalence, associated factors, and impact on outcomes of the OPM study

Background Clinical inertia, defined as the failure to initiate or intensify therapy when clinically indicated, represents a major and under-addressed barrier to achieving cardiovascular risk (CVR) factor control in primary care. Despite the availability of evidence-based guidelines and effective pharmacological treatm...

José Abellán Alemán, Pablo Sánchez-Rubio Lezcano, D. Pardo et al. · 0 citations
Open access Sep 2026

Exploration of a co-care service for chronic care management in patients with hypertension: A participatory qualitative study (Phase 1)

Introduction In Switzerland, more than 80% of diagnosed individuals with hypertension are prescribed at least one blood pressure-lowering agent, yet 60% have uncontrolled blood pressure. To address this burden, co-care has been shown to improve systolic blood pressure control and to be cost-effective. Currently, no co-...

Fanny Mulder, Marina Lopes Cardoso, Alessia Romer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.